Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Briefing Explores Associations between Air Pollution and Health Outcomes

Published: Monday, February 25, 2013
Last Updated: Monday, February 25, 2013
Bookmark and Share
Health risks associated with high levels of air pollution may vary between neighborhoods across large urban populations.

Lance Waller, PhD, chair of Biostatistics and Bioinformatics at Emory's Rollins School of Public Health, will present preliminary work that explores relationships between high-levels of air pollution exposure and health effects at a press briefing hosted by the American Association for the Advancement of Science on February 17, at 2 p.m. EST, in Boston.

During the briefing, Waller will summarize his joint work with the Southeastern Center for Air Pollution Epidemiology (SCAPE), funded by the Environmental Protection Agency.  SCAPE tests air pollution levels in various areas of Metro Atlanta and their health effects, based on data from associated emergency room visits, in order to determine relationships to exposure. Waller's research will assess the general findings of SCAPE to identify spatial uncertainties in exposures.

"SCAPE has identified geographically-referenced air pollution levels and health outcomes," explains Waller.  "Our work will analyze these data to determine whether the effects seen city-wide mirror those observed in local neighborhoods."

The team will also identify communities with higher risk levels and examine potential roles of behavioral connections such as prolonged outdoor activity and socio-economic status.

Satellite data –data collected by measuring light—will be collected to determine air pollution levels in areas where ground monitors—data collected by filters-- are not located.  Assessments made on the associations between monitored levels and satellite levels will help observe relationships over a broader region.

A second part of the research looks at pollution levels and the association specifically with respiratory diseases, as certain communities show stronger associations with these outcomes.  Waller hopes that his research will lead to improved understanding of the causes of these outcomes.

"Each component of our research is essential because it generates potential solutions," says Waller.  "If we can identify areas that are healthier, we may be able to identify why they are healthier and use these solutions as models to implement in other communities."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanoparticles Deliver Anticancer Cluster Bombs
Researchers at Emory have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.
Saturday, April 16, 2016
Mixed-Strain Malaria Influences Drug Resistance
Scientists have documented for the first time how competition among different malaria parasite strains in human hosts could influence the spread of drug resistance.
Thursday, March 24, 2016
DTRA Awards $9.7M Contract for Drug Development
The Defense Threat Reduction Agency (DTRA) has awarded Emory University a $9.7M contract to develop drugs to treat infections caused by emerging and man-made viral threats. Under the contract, the DTRA funds will be used to advance the development of the lead drug candidate.
Thursday, February 04, 2016
Predicting Flu Vaccine Efficacy
Researchers reveal novel molecular signatures that could be used to predict which individuals are most likely to respond positively to vaccination.
Thursday, December 17, 2015
How White Blood Cells Limit Muscle Regeneration
Researchers have identified a protein produced by white blood cells that puts the brakes on muscle repair after injury.
Monday, August 10, 2015
First Look At Hospitalized Ebola Survivors' Immune Cells Could Guide Vaccine Design
Emory and CDC researchers have been examining immune cells obtained from four patients treated at Emory University Hospital in 2014.
Wednesday, March 11, 2015
One-minute Point-of-Care Anemia Test Shows Promise in New Study
Test produces results in about 60 seconds and requires no electrical power.
Tuesday, September 16, 2014
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Tuesday, September 16, 2014
Quality Control Guidelines Proposed for Genomics Studies
Guidelines for researchers studying the effects of rare genetic variants.
Friday, April 25, 2014
Steering Stem Cells with Magnets
Magnets could be a tool for directing stem cells’ healing powers to treat conditions such as heart disease or vascular disease.
Thursday, July 18, 2013
X-ray Research at Diamond Paves Way for Lassa Fever Vaccine and Drug Development
Research shows how the Lassa virus remains invisible to the human defence system and causes thousands of deaths each year.
Friday, November 19, 2010
Emory Study Yields Clue to How Stem Cells Form
Study shows some of the first direct evidence of a process required for epigenetic reprogramming between generations.
Tuesday, April 21, 2009
Researchers Discover Strategy for Predicting the Immunity of Vaccines
Emory study reveals how a highly successful vaccine triggers robust immune responses.
Monday, November 24, 2008
NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Emory University's School of Medicine has received a $3.6M grant form NIH to study a human genetic variation linked to schizophrenia.
Tuesday, May 22, 2007
Scientists Determine How Tumor Gene Controls Growth
Researchers have uncovered details about how Tsg 101 Gene causes cells to overgrow.
Monday, November 07, 2005
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!